Morten Albrechtsen

Morten Albrechtsen is an MD and BBA (‘HD’ in marketing, CBS). Morten is a seasoned entrepreneur with a strong medical, commercial and financial background. The expertise is gained within a broad range of therapeutic areas and with both drugs and devices. The development expertise includes all stages, pre-clinical, clinical, and post-market development, and with various disciplines. The commercial expertise is gained internationally and includes sales through partners, affiliates, direct to patients, hospitals, and direct to end-users. It also includes business development with licensing and corporate deals. Previously, Morten has developed and launched new health care products and concepts internationally, e.g. in Nycomed Pharma, now Takeda Pharmaceuticals Ltd. (pain control), Nanovi (brought a new cancer product to the market in Europe and prepared it for the US), and Boehringer Ingelheim GmbH (hospital sales, cardiovascular, stroke female health and pain control). Morten has also a strong experience from early clinical development in e.g. Enkam A/S (CNS drug development including medicines for Alzheimer’s disease, Parkinson’s disease, and depression) and several others.